These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7678103)

  • 1. Epithelial markers to detect occult microinvasion in serous ovarian tumors.
    Hanselaar AG; Vooijs GP; Mayall B; Ras-Zeijlmans GJ; Chadha-Ajwani S
    Int J Gynecol Pathol; 1993 Jan; 12(1):20-7. PubMed ID: 7678103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
    Sangoi AR; McKenney JK; Dadras SS; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases.
    Maniar KP; Wang Y; Visvanathan K; Shih IeM; Kurman RJ
    Am J Surg Pathol; 2014 Jun; 38(6):743-55. PubMed ID: 24441661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
    Shappell HW; Riopel MA; Smith Sehdev AE; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 2002 Dec; 26(12):1529-41. PubMed ID: 12459620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial antigens in carcinomas of the ovaries. Relation to histological classification.
    Jørgensen A; Nielsen K
    APMIS; 1994 Jul; 102(7):533-7. PubMed ID: 7522476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
    Prat J; De Nictolis M
    Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic problems of ovarian mucinous borderline tumors].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Jun; 53(2):127-33. PubMed ID: 19581178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
    Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
    Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p16, p53, CD24, EpCAM and calretinin in serous borderline tumors of the ovary.
    Aktaş IY; Buğdayci M; Usubütün A
    Turk Patoloji Derg; 2012; 28(3):220-30. PubMed ID: 23011824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
    Riopel MA; Ronnett BM; Kurman RJ
    Am J Surg Pathol; 1999 Jun; 23(6):617-35. PubMed ID: 10366144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion).
    Tavassoli FA
    Mod Pathol; 1988 Nov; 1(6):407-14. PubMed ID: 2464824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
    Vereczkey I; Tóth E; Orosz Z
    Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current issues in the pathology of ovarian cancer.
    Rabban JT; Bell DA
    J Reprod Med; 2005 Jun; 50(6):467-74. PubMed ID: 16050571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
    Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is stromal microinvasion in primary mucinous ovarian tumors with "mucin granuloma" true invasion?
    Kim KR; Lee HI; Lee SK; Ro JY; Robboy SJ
    Am J Surg Pathol; 2007 Apr; 31(4):546-54. PubMed ID: 17414101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the landscape of ovarian serous borderline tumors.
    Messini I; Doulgeraki T; Chrysanthakis D; Yiannou P; Gavresea T; Papadimitriou C; Panoskaltsis T; Voulgaris Z; Vlachos A; Pavlakis K
    Int J Gynecol Cancer; 2019 Mar; 29(3):572-578. PubMed ID: 30659030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
    Yamada K; Ohkawa K; Joh K
    Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors or the ovary: a clinicopathologic, immunohistochemical, and Serological study.
    De Nictolis M; Garbisa S; Lucarini G; Goteri G; Masiero L; Ciavattini A; Garzetti GG; Stetler-Stevenson WG; Fabris G; Biagini G; Prat J
    Int J Gynecol Pathol; 1996 Apr; 15(2):102-9. PubMed ID: 8786198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.